scholarly article | Q13442814 |
P50 | author | Paola Scarcella | Q56451070 |
Marina Giuliano | Q56451073 | ||
Mauro Andreotti | Q56451074 | ||
Maria Cristina Marazzi | Q56451078 | ||
Stefano Vella | Q56451079 | ||
Giuseppe Liotta | Q56816205 | ||
Ersilia Buonomo | Q56451069 | ||
Maria F. Pirillo | Q40867241 | ||
Leonardo Palombi | Q43217518 | ||
P2093 | author name string | Roberta Amici | |
Susanna Ceffa | |||
Sandro Mancinelli | |||
Haswell Jere | |||
Jean-Baptiste Sagno | |||
Martin Maulidi | |||
P2860 | cites work | Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. | Q45770931 |
Malnutrition among children in rural Malawian fish-farming households. | Q46251484 | ||
Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants | Q46328518 | ||
Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety | Q46808222 | ||
Specific immunoglobulin A antibodies in maternal milk and delayed Helicobacter pylori colonization in Gambian infants | Q47911117 | ||
??? | Q28085018 | ||
Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis | Q28731813 | ||
Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding--the Kisumu Breastfeeding Study, Kenya: a clinical trial | Q33863552 | ||
Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? | Q34313201 | ||
Antiretroviral regimens in pregnancy and breast-feeding in Botswana | Q34395082 | ||
Early weaning increases diarrhea morbidity and mortality among uninfected children born to HIV-infected mothers in Zambia | Q34754843 | ||
Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana | Q35386228 | ||
Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi | Q35452458 | ||
Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora rand | Q36086970 | ||
Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil | Q36221392 | ||
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission | Q36231035 | ||
Child mortality levels and trends by HIV status in Blantyre, Malawi: 1989-2009. | Q36279151 | ||
Field effectiveness of combination antiretroviral prophylaxis for the prevention of mother-to-child HIV transmission in rural Zambia | Q37330892 | ||
Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis | Q37335159 | ||
Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania | Q37336328 | ||
Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program | Q37412402 | ||
Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial | Q38967453 | ||
Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. | Q39335189 | ||
Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study | Q43281055 | ||
Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial | Q44208352 | ||
Childhood malnutrition and its predictors in rural Malawi. | Q45163886 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Malawi | Q1020 |
maternal health | Q6786626 | ||
prevention of HIV/AIDS | Q7242372 | ||
HIV transmission | Q49029021 | ||
anti-retroviral agent | Q50430310 | ||
P304 | page(s) | e68950 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery | |
P478 | volume | 8 |
Q47547085 | 24-month HIV-free survival among infants born to HIV-positive women enrolled in Option B+ program in Kigali, Rwanda: The Kabeho Study |
Q36888760 | An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort |
Q40894200 | Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children |
Q40540194 | CMV infection in a cohort of HIV-exposed infants born to mothers receiving antiretroviral therapy during pregnancy and breastfeeding |
Q53701787 | Deficit of IgG2 in HIV-positive pregnant women is responsible of inadequate IgG2 levels in their HIV-uninfected children in Malawi. |
Q56909894 | Does U=U for breastfeeding mothers and infants? Breastfeeding by mothers on effective treatment for HIV infection in high-income settings |
Q38385724 | Drug resistance mutations 18 months after discontinuation of nevirapine-based ART for prevention of mother-to-child transmission of HIV in Malawi |
Q93191969 | Dynamics of immunoglobulin G subclasses during the first two years of life in Malawian infants born to HIV-positive mothers |
Q28070420 | HIV-free survival at 12-24 months in breastfed infants of HIV-infected women on antiretroviral treatment |
Q41760045 | Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding. |
Q46142443 | Laboratory confirmation of clinically diagnosed malaria in a cohort of HIV-infected mothers and their children in Malawi |
Q39520236 | Levels of bone markers in a population of infants exposed in utero and during breastfeeding to tenofovir within an Option B+ programme in Malawi. |
Q40060234 | Low mother-to-child HIV transmission rate but high loss-to-follow-up among mothers and babies in Mandalay, Myanmar; a cohort study. |
Q38930221 | Maternal and neonatal outcomes among women with HIV infection and their infants in Malawi |
Q47274035 | Monitoring Prevention Impact of Mother-to-Child Transmission of HIV in Concentrated Epidemics With Program and Survey Data. |
Q55546839 | Morbidity and mortality in HIV-exposed uninfected children |
Q33787641 | Postnatal HIV transmission in breastfed infants of HIV-infected women on ART: a systematic review and meta-analysis |
Q40962161 | Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi |
Q47546312 | Soluble CD14 levels in plasma and breastmilk of Malawian HIV+ women: Lack of association with morbidity and mortality in their exposed infants |
Q36144271 | Temporal changes in the outcomes of HIV-exposed infants in Kinshasa, Democratic Republic of Congo during a period of rapidly evolving guidelines for care (2007-2013). |
Q34266269 | Viral sequence analysis of HIV-positive women and their infected children: insight on the timing of infection and on the transmission network |
Q43049052 | Weight changes during and after 6 months of breastfeeding in HIV-infected mothers receiving antiretroviral therapy in Malawi |
Search more.